Alignment Healthcare (ALHC) CEO receives 338,434 restricted stock units award

Rhea-AI Filing Summary

KAO JOHN E reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare, Inc. reported that Chief Executive Officer John E. Kao received a grant of 338,434 restricted stock units of Common Stock on March 13, 2026. The grant was made at no cash purchase price as a stock-based compensation award.

Each restricted stock unit represents the right to receive one share of Common Stock and will vest approximately one third on each of the first three anniversaries of the grant date, subject to Mr. Kao’s continued service with the company. Following this grant, he holds 1,857,914 shares directly and 2,472,641 shares indirectly through the JEK Trust, of which he is trustee.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KAO JOHN E

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD., SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		338,434(1)	A	$0	1,857,914	D
Common Stock								2,472,641	I	See Footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 338,434 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

2. Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Alignment Healthcare (ALHC) report for CEO John E. Kao?

Alignment Healthcare reported a stock-based compensation grant to CEO John E. Kao of 338,434 restricted stock units on March 13, 2026. Each unit represents one share of Common Stock, vesting over three years, subject to his continued service with the company.

How do John E. Kao’s new restricted stock units in ALHC vest over time?

The 338,434 restricted stock units granted to John E. Kao vest in three approximately equal installments. One third vests on each of the first three anniversaries of the March 13, 2026 grant date, contingent on his continued service with Alignment Healthcare.

Did Alignment Healthcare’s CEO buy ALHC shares on the open market in this Form 4?

No, the Form 4 shows a grant of 338,434 restricted stock units to CEO John E. Kao at no cash purchase price. This is a compensation-related award, not an open-market purchase or sale of Alignment Healthcare common stock.

What are John E. Kao’s direct and indirect ALHC share holdings after this grant?

After the restricted stock unit grant, John E. Kao directly owns 1,857,914 shares of Alignment Healthcare common stock. He also indirectly holds 2,472,641 shares through the JEK Trust dated February 8, 2021, where he serves as trustee.

What is the JEK Trust mentioned in Alignment Healthcare’s Form 4 filing?

The JEK Trust, dated February 8, 2021, is an entity that holds Alignment Healthcare securities for which John E. Kao is trustee. The Form 4 shows 2,472,641 ALHC shares held indirectly through this trust, in addition to his directly held shares.